Retired NFL Linebacker Overcomes ADHD, Invests in Mental Health Platform DoneMental health platform Done makes its debut Share XRetired NFL Linebacker Overcomes ADHD, Invests in Mental Health Platform Donehttps://pharmaphorum.com/partner-content/retired-nfl-linebacker-overcomes-adhd-invests-in-mental-health-platform-done/
MindMed aims for Nasdaq listing after Compass’ magic mushroom-fuelled IPOCompass Pathways and its potential magic mushroom depression drug went public last week – and now psychedelic therapy Share XMindMed aims for Nasdaq listing after Compass’ magic mushroom-fuelled IPOhttps://pharmaphorum.com/news/mindmed-aims-for-nasdaq-listing-after-compass-magic-mushroom-fuelled-ipo/
BioXcel’s phase 3 schizophrenia film has blockbuster potential, say analystsA sublingual film for acute agitation in schizophrenia and bipolar disorder from BioXcel has blockbuster potential that could Share XBioXcel’s phase 3 schizophrenia film has blockbuster potential, say analystshttps://pharmaphorum.com/news/bioxcel/
Compass plans $100m IPO to fund magic mushroom depression drugUK biotech Compass Pathways is planning a $100 million US IPO as it seeks to further develop its Share XCompass plans $100m IPO to fund magic mushroom depression drughttps://pharmaphorum.com/news/compass-plans-100m-ipo-to-fund-magic-mushroom-depression-drug/
NICE rejects Janssen’s depression spray Spravato for second timeNICE has rejected regular NHS funding for Janssen’s depression spray Spravato (esketamine) for a second time, although the Share XNICE rejects Janssen’s depression spray Spravato for second timehttps://pharmaphorum.com/news/nice-rejects/
Digital health firm Lyra enters unicorn territory after fundraisingDigital health startup Lyra Health has raised $110 million in fourth-round financing, raising its value above the $1 Share XDigital health firm Lyra enters unicorn territory after fundraisinghttps://pharmaphorum.com/news/digital-health-firm-lyra-enters-unicorn-territory-after-fundraising/
Why the next blockbuster in mental health might be a video gameDavid Keene looks at the difficulties faced in treating mental health patients and how digital technologies are changing Share XWhy the next blockbuster in mental health might be a video gamehttps://pharmaphorum.com/views-analysis-digital/why-the-next-blockbuster-in-mental-health-might-be-a-video-game/
Digital depression therapy offers hope during COVID-19 pandemicA new digital therapy is aiming to tackle depression during the COVID-19 pandemic, using a brain stimulation headset Share XDigital depression therapy offers hope during COVID-19 pandemichttps://pharmaphorum.com/news/digital-depression-therapy-offers-hope-during-covid-19-pandemic/
Mental health platform helps students facing exam results during pandemicThe UK digital mental health support platform Kooth has joined with five of the UK’s well known Instagram Share XMental health platform helps students facing exam results during pandemichttps://pharmaphorum.com/news/digital-mental-health-platform-supports-students-during-pandemic-exam-results-season/